As of 2025-07-15, the Relative Valuation of Biogen Inc (BIIB) is 186.16 USD. This relative valuation is based on P/E multiples. With the latest stock price at 133.11 USD, the upside of Biogen Inc based on Relative Valuation is 39.9%.
The range of the Relative Valuation is 137.69 - 251.84 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 22.1x | 18.6x |
| Forward P/E multiples | 11.8x - 21.6x | 15.8x |
| Fair Price | 137.69 - 251.84 | 186.16 |
| Upside | 3.4% - 89.2% | 39.9% |
| Date | P/E |
| 2025-07-14 | 13.19 |
| 2025-07-11 | 13.29 |
| 2025-07-10 | 13.40 |
| 2025-07-09 | 13.18 |
| 2025-07-08 | 13.32 |
| 2025-07-07 | 12.89 |
| 2025-07-03 | 13.16 |
| 2025-07-02 | 13.19 |
| 2025-07-01 | 12.88 |
| 2025-06-30 | 12.44 |
| 2025-06-27 | 12.49 |
| 2025-06-26 | 12.57 |
| 2025-06-25 | 12.61 |
| 2025-06-24 | 12.51 |
| 2025-06-23 | 12.36 |
| 2025-06-20 | 12.58 |
| 2025-06-18 | 12.53 |
| 2025-06-17 | 12.54 |
| 2025-06-16 | 12.98 |
| 2025-06-13 | 12.94 |
| 2025-06-12 | 13.11 |
| 2025-06-11 | 13.18 |
| 2025-06-10 | 13.42 |
| 2025-06-09 | 13.29 |
| 2025-06-06 | 13.19 |
| 2025-06-05 | 12.91 |
| 2025-06-04 | 13.06 |
| 2025-06-03 | 13.06 |
| 2025-06-02 | 12.99 |
| 2025-05-30 | 12.86 |
| 2025-05-29 | 13.15 |
| 2025-05-28 | 12.63 |
| 2025-05-27 | 12.72 |
| 2025-05-23 | 12.46 |
| 2025-05-22 | 12.51 |
| 2025-05-21 | 12.56 |
| 2025-05-20 | 12.93 |
| 2025-05-19 | 12.82 |
| 2025-05-16 | 12.44 |
| 2025-05-15 | 12.25 |
| 2025-05-14 | 11.92 |
| 2025-05-13 | 12.20 |
| 2025-05-12 | 12.32 |
| 2025-05-09 | 11.71 |
| 2025-05-08 | 11.73 |
| 2025-05-07 | 11.61 |
| 2025-05-06 | 11.57 |
| 2025-05-05 | 12.06 |
| 2025-05-02 | 12.24 |
| 2025-05-01 | 11.98 |